SH Alshemmari, MA Siddiqui, R Pandita… - Acta …, 2024 - karger.com
Introduction: Despite recent advances in diagnosis, prognostication, and treatment options, chronic lymphocytic leukemia (CLL) is still a largely incurable disease. New concepts on …
A Fresa, F Autore, A Piciocchi, G Catania… - Blood …, 2022 - ashpublications.org
Obinutuzumab (G) in combination with chlorambucil (Chl) has been approved in Italy in 2017 as frontline treatment for patients with chronic lymphocytic leukemia (CLL) and …
F Simon, A Giza, S Robrecht, AM Fink… - Leukemia & …, 2022 - Taylor & Francis
Patients aged 80 years and older make up a fifth of patients with CLL but are underrepresented in clinical trials. We analyzed the outcomes of these patients treated with …
Introduction: Despite recent advances in diagnosis, prognostication, and treatment options, chronic lymphocytic leukemia (CLL) is still a largely incurable disease. New concepts on …
Background With an estimated 18,740 new cases in 2023, chronic lymphocytic leukemia (CLL) accounts for nearly one quarter of all newly diagnosed leukemias each year. 1, 2 …